The main objective of this study was to evaluate the effects of heat, Momordicilin and antibiotics on Coronavirus. This study selected 12 individuals tested positive for COVID-19 which included two healthcare providers, one friend, a Massachusetts' family, and six family members in Florida including the inventor. All individuals were testing positive for COVID-19 excluding two individuals and inventor who didn't test. They had fever, mild headache, chest pain, cough and loss of appetite. All individuals were taking facial steaming(vapor) between 5-15 minutes for four consecutive days, a cup of Cerasee Tea with lime/lemon(Extracted-Momordicilin) three times a day for seven days and with or without any antibiotic as prescribed by their physicians. All patients felt relief immediately after taking the first dose of heat and Asosi Tea or antibiotic. All symptoms were gone in five days. After seven days, all individuals had no symptoms and re-tested. The results came negative for COVID-19. These results indicate that combination of heat, momordicilin and with or without antibiotic treat COVID-19.

An electrically-heatable plaster that comprises a self-adhesive skin contact layer, an electrically-conductive textile fabric in which electrically-conductive fibres are in contact with one another, as a heating element, and optionally at least one active substance, as well as to a method for production and the use of same for local heat therapy and/or transdermal application of active substances.

An assembly for the thermal treatment and moisture treatment of physical conditions, the assembly including, a first thermal pack having a body, the body having a first face and a second face, the first face having a first protrusion. The assembly further includes a sleeve operatively arranged to receive the first thermal pack, the sleeve having a first surface. The assembly also includes a medicament pad arranged to be removably secured to the first surface of the sleeve.

A device comprising a housing having a handle end and a treatment end. The treatment end is configured to provide an antimicrobial treatment and a heat treatment. The treatment end comprises an applicator having an applicator surface for providing at least the heat treatment. The device includes a heat generation unit configured to heat the applicator surface in use, a source of antimicrobial agent, and a control unit operatively connected to at least the heat generation unit for controlling the heat generation unit. The device can be a hand-held device and used to apply topical treatment to a treatment area of a subject.

Provided are devices for therapeutic interaction with an Abreu brain thermal tunnel (ABTT) terminus. Such devices are configured to provide one or more drugs to an ABTT terminus, and may provide heat to or remove heat from the ABTT terminus while providing the one or more drugs.

A patch (10) comprising: a nonwoven fabric (1); and an adhesive layer (2) on the nonwoven fabric (1), wherein the adhesive layer (2) comprises a cool feeling agent, a local anesthetic and/or an anti-inflammatory analgesic, and water, and the adhesive layer (2) has a maximum thickness of 0.50 mm or more.

A cooling sheet comprising: a backing layer; an adhesive agent layer; and a liner layer for protecting the adhesive agent layer, wherein the adhesive agent layer contains water at 65 to 85% by mass based on a total mass of the adhesive agent layer, polyalkylene glycol monooleate at 0.12 to 0.7% by mass based on the total mass of the adhesive agent layer, polyvinyl alcohol at 3 to 10% by mass based on the total mass of the adhesive agent layer, polyacrylic acid at 0.5 to 5% by mass based on the total mass of the adhesive agent layer, and a parahydroxybenzoate at 0.01 to 1% by mass based on the total mass of the adhesive agent layer, and a mass ratio of a content of the polyvinyl alcohol to a content of the polyacrylic acid is in a range of 1.2:1 to 5:1.

A compress for treating and preventing radiation dermatitis, comprising a reservoir layer configured to store and release a mixture of skin-cooling ingredients, wherein the compress is cold before applying to skin exposed to radiation therapy or becomes cold after applying to skin exposed to radiation therapy.

Thermal dressings consist of conformable containment pack to be placed on or wrapped around a part of the body providing thermal therapeutics with or without; sensing as a diagnostic tool and/or medical intervention material. Containment pack has an inner layer closest to the skin and an outer layer furthest from the skin; containment pack has at least one volume deflector configure to provide areas of positive and negative curvature when in use; inner layer positive curvature is an outward protrusion for compression directed into skin for splinting and sensor location, and the negative curvature has gap for circuitry and medical intervention material. Volume deflectors are positioned to provide contour matching portions of body covered by said containment pack; and containment pack has a preloaded first material needed to create a thermal reaction.

A thermal control unit supplies temperature controlled fluid to a patient to control the patient's temperature. The thermal control unit includes a fluid outlet, fluid inlet, heat exchanger, pump, patient temperature probe port, user interface, and controller. The controller receives patient temperature readings from the patient temperature probe port and controls a temperature of the circulating fluid in a first manner when no event data is received regarding treatment of the patient. The controller controls a temperature of the circulating fluid in a second and different manner when event data is received. The event data may relate to medication and/or fluid administered to the patient. The different manners include determining a target fluid temperature in using different inputs and/or alarming in different manners. In some cases, the controller pauses the use of the patient temperature readings while continuing to deliver temperature controlled fluid to the patient.